The different clinical phenotypes of SMA were further explained by increasing the depth of sequencing and optimizing the algorithms of data analysis to accurately call copy number variants of SMN1 and SMN2. In this study, SMA carrier screening was conducted in three stages. Here, SMN1 is linked to proximal spinal muscular atrophy.